| Katherine Kreitzer, LPC | |
|
15850 W Bluemound Rd, Ste 208, Brookfield, WI 53005-6022 | |
| (262) 719-5898 | |
| Not Available |
| Full Name | Katherine Kreitzer |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 15850 W Bluemound Rd, Brookfield, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598012890 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 4718-125 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Kreitzer, LPC 15850 W Bluemound Rd, Ste 208, Brookfield, WI 53005-6022 Ph: (262) 719-5898 | Katherine Kreitzer, LPC 15850 W Bluemound Rd, Ste 208, Brookfield, WI 53005-6022 Ph: (262) 719-5898 |
News Archive
SC Johnson, A Family Company, today announced a collaboration with the Bill & Melinda Gates Foundation on global efforts to combat malaria. The organizations will jointly support research programs conducted by Cornell University Center for Sustainable Global Enterprise and a consortium of Indonesian research institutions to advance the development and use of consumer products in the fight against the spread of the disease.
According to a controversial new study, researchers say men's faces reveal their interest in having children, and women subconsciously pick up these subtle cues when choosing a partner.
Scientists at Fred Hutchinson Cancer Research Center have, for the first time, induced a state of reversible metabolic hibernation in mice. This achievement, the first demonstration of "hibernation on demand" in a mammal, ultimately could lead to new ways to treat cancer and prevent injury and death from insufficient blood supply to organs and tissues.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
› Verified 7 days ago
Amanda L Franzen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 16535 W Bluemound Rd Ste 305, Brookfield, WI 53005 Phone: 800-438-1772 Fax: 262-345-5562 | |
Kristen Stodola, Counselor Medicare: Medicare Enrolled Practice Location: 17100 W North Ave, Brookfield, WI 53005 Phone: 262-244-6177 | |
Ann Elizabeth Brunner, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 16655 W Bluemound Rd Ste 330, Brookfield, WI 53005 Phone: 262-786-9184 Fax: 262-786-1906 | |
Emily Kathryn Olson, ATR, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 12630 W North Ave Bldg E, Brookfield, WI 53005 Phone: 262-785-1008 | |
Susan Marie Condon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 18000 W Sarah Ln, Brookfield, WI 53045 Phone: 262-267-8560 | |
Leah K Stadel, Counselor Medicare: Not Enrolled in Medicare Practice Location: 16535 W Bluemound Rd Ste 305, Brookfield, WI 53005 Phone: 800-438-1772 Fax: 262-345-5562 | |
Mrs. Kewonia Hogans-rhodes, MS, CRC, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 13105 W Bluemound Rd Ste 100, Brookfield, WI 53005 Phone: 262-754-5925 |